These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15041339)

  • 1. Experience with cyclosporine in pediatric renal transplantation.
    Willetts IE; Trompeter RS
    Transplant Proc; 2004 Mar; 36(2 Suppl):211S-215S. PubMed ID: 15041339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of cyclosporine on the development of immunosuppressive therapy--pediatric transplantation using cyclosporine.
    Hoyer PF; Vester U
    Transplant Proc; 2004 Mar; 36(2 Suppl):197S-202S. PubMed ID: 15041336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine in pediatric kidney transplantation.
    Pape L; Ehrich JH; Offner G
    Transplant Proc; 2004 Mar; 36(2 Suppl):203S-207S. PubMed ID: 15041337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with cyclosporine in the Canary Islands.
    Hernández D
    Transplant Proc; 2004 Mar; 36(2 Suppl):120S-124S. PubMed ID: 15041320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxic aspects of cyclosporine.
    Cattaneo D; Perico N; Gaspari F; Remuzzi G
    Transplant Proc; 2004 Mar; 36(2 Suppl):234S-239S. PubMed ID: 15041344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of cyclosporine in renal transplantation: experience at the University of Padua.
    Furian L; Baldan N; Rigotti P
    Transplant Proc; 2004 Mar; 36(2 Suppl):148S-151S. PubMed ID: 15041326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of the use of cyclosporine in renal transplantation.
    Yoshimura N; Okamoto M; Akioka K; Kaihara S
    Transplant Proc; 2004 Mar; 36(2 Suppl):181S-185S. PubMed ID: 15041333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine renal dysfunction.
    Vítko S; Viklický O
    Transplant Proc; 2004 Mar; 36(2 Suppl):243S-247S. PubMed ID: 15041346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of performance factors affecting two formulations of cyclosporine in pediatric renal transplant patients.
    Acott PD; Crocker JF; Renton KW
    Transplant Proc; 2006 Nov; 38(9):2835-41. PubMed ID: 17112843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients.
    Oellerich M; Armstrong VW; Streit F; Weber L; Tönshoff B
    Clin Biochem; 2004 Jun; 37(6):424-8. PubMed ID: 15183289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
    Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
    Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of renal function during maintenance therapy with cyclosporine.
    Serón D; Moreso F
    Transplant Proc; 2004 Mar; 36(2 Suppl):257S-260S. PubMed ID: 15041349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
    Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
    Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with cyclosporine in heart transplantation.
    Sivathasan C
    Transplant Proc; 2004 Mar; 36(2 Suppl):346S-348S. PubMed ID: 15041365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with cyclosporine in endogenous uveitis posterior.
    Hesselink DA; Baarsma GS; Kuijpers RW; van Hagen PM
    Transplant Proc; 2004 Mar; 36(2 Suppl):372S-377S. PubMed ID: 15041371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
    Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
    Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss?
    He X; Johnston A
    Transplant Proc; 2004 Jun; 36(5):1321-6. PubMed ID: 15251323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine: from renal transplantation to autoimmune diseases.
    Ponticelli C
    Ann N Y Acad Sci; 2005 Jun; 1051():551-8. PubMed ID: 16126995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.